Modification of prostanoid secretion in endothelial cells by amphotericin B acting synergistically with interleukin-1β: Possible explanation of proinflammatory effects

Journal of Infectious Diseases

Volumn 190, Issue 5, 2004, Pages 1026-1032

  Camacho, Mercedes ^a   Gerbolés, Esther ^a   Soler, Marta ^a   Vila, Luís ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ARACHIDONIC ACID; CYCLOOXYGENASE 2; HISTAMINE; INTERLEUKIN 1BETA; PROSTACYCLIN; PROSTAGLANDIN H2; PROSTANOID;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG FORMULATION; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMPHOTERICIN B; CELL LINE; CELLS, CULTURED; DRUG COMBINATIONS; DRUG SYNERGISM; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1; LIPOSOMES; MACROPHAGES; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PROSTAGLANDINS; RECOMBINANT PROTEINS; UMBILICAL VEINS;

EID: 4344627568     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/423207     Document Type: Article

References (21)

1. Szoka FC Jr, Tang M. Amphotericin B formulated in liposomes and lipid based systems: a review. J Liposome Res 1993; 3:363-75.
2. Lyman CA, Walsh TJ. Systematically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs 1992; 44:9-35.
3. Martin E, Stuben A, Gorz A, Weller U, Bhakdi S. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob Agents Chemother 1994; 38:13-22.
4. Chia JK, Pollack M. Amphotericin B induces tumor necrosis factor production by murine macrophages. J Infect Dis 1989; 159:113-6.
5. Rogers PD, Kramer RE, Chapman SW, Cleary JD. Amphotericin B-induced interleukin-1β expression in human monocytic cells is calcium and calmodulin dependent. J Infect Dis 1999; 180:1259-66.
6. Cutaia M, Bullard SR, Rudio K, Rounds S. Characteristics of amphotericin B-induced endothelial cell injury. J Lab Clin Med 1993; 121:244-56.
7. Sawaya BP, Weihprecht H, Campbell WR, et al. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats. J Clin Invest 1991; 87:2097-107.
8. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 1999; 31:551-7.
9. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263:663-5.
10. Camacho M, López-Belmonte J, Vila L. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and PGI-synthase activity. Circ Res 1998; 83:353-65.
11. 2 in mixed incubations of endothelial cells and aspirin-treated platelets strongly depends on the prostaglandin I-synthase activity. Thromb Res 2000; 99:155-64.
12. Soler M, Camacho M, Escudero JR, In̄iguez MA, Vila L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res 2000; 87:504-7.
13. Le Breton GC, Venton DL, Enke SE, Halushka PV. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/ endoperoxide receptor. Proc Natl Acad Sci USA 1979; 76:4097-101.
14. 2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol 1998; 112:464-70.
15. 2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells. Clin Exp Immunol 2000; 120:71-8.
16. 2. Adv Prostaglandin Thromboxane Res 1980; 6:129-37.
17. Camacho M, Godessart N, Antón R, García M, Vila L. Interleukin-1 enhances the ability of cultured umbilical vein endothelial cells to oxidize linoleic acid. J Biol Chem 1995; 270:17279-86.
18. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26:171-6.
19. 4 by transcellular biosynthesis. J Invest Dermatol 1992; 98: 333-9.
20. Soler M, Camacho M, Molins-Pujol AM, Vila L. Effect of an imidazolineoxyl nitric oxide on prostaglandin synthesis in experimental shock: possible role of nitrogen dioxide in prostacyclin synthase inactivation. J Infect Dis 2001; 183:105-12.
21. 2 as a major prostanoid. Kidney Int 2001; 59: 1283-9.